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Table 1 
STEMI UAINSTEMI STABLECAD CONTROLS P 
[MMP-P] (mcg/ml)) 554.9+164.3 502.4k170.0 584.8*215.4 494.0*178.3 0.160 
MMP-2 ACTIVITY 33.0+21.5 33.9r14.9 35.7*15.5 42.4el4.6 0.073 
(absorbance unlfs) 
(MMP-31 (mcg/ml) 33.6+15.7 25.0*9.0 28.0+13.6 29.6T12.5 0.130 
[MMP-91 (mcg/ml) 192.4+123.9 141.5+105.2 82.9+50.1 114.3i74.9 <0.001 
MMP-9 ACTIVITY 34.8*21.2 30.5*17.7 24.6~10.4 29.5k18.9 0.222 
(absorbance unlfs) 
[TIMP-l] (mcglml) 279.9a72.0 277.5k50.0 298.6243 0 25O.Ozt49.5 0.002 
[TIMP-21 (mcgiml) 25.3kll.9 26.2kl3.1 23.3k7.2 38.9+12.3 <O.col 
9:15 a.m. 
840-4 Lipoprotein-Associated Phospholipase A2 is 
Associated With Angiographic Coronary Artery Disease 
on Univariate Analysis but Loses Independent 
Predictive Value in a Multivariate Model 
Emmanouil S. Bnlakls, Joseph P. McConnell, Ryan .I. Lennon. Jeffrey G. Meyer, Peter B. 
Berger, Mayo Cknic, Rochester, MN 
Background: Lipoprofeln-associated phospholipase A2 (Lp-PLA2) has been recently 
implicated in the pathogen&s of atherosclerosis Lp-PLAP has been correlated with 
angiographic coronary artery disesase (CAD) in only one study (w148). In that study, 
Lp-PLAP levels were higher in paf~enfs (pfs) with CAD than controls, but coronary 
angiography was not performed in all of the pts or controls. 
Methods: We analyzed the associaflon between Lp-PLAP level and CAD in 504 consec- 
ufwe pfs undergong clinically indicated coronary angiography between 7198 and l/99. 
Lp-PLAP levels were measured using an enzyme-linked immunoassay (diaDexus, Inc, 
South San Francisco, Callfornn). 
Results: Mean age was 6Oifl years; 38% were women; 24% had normal coronary 
arier,es (<lo% stenoses); 22% had sfenoses 10.50%; and 17%. 16%. and 21% had sin- 
gle, double, and triple vessel disease (>50% sfenoses), respectively. Overall, mean (t 
SD) Lp-PLAP (ng/mL) was 244 * 92. Mean Lp-PLA2 was higher I” pfs with significant 
CAD, defined as >50% luminal stenosis (252 f. 97 vs. 235 * 83, p=O.O34). Mean (+ SD) 
Lp-PLAP in pts with <lo% luminal stenosis. IO%-50% luminal stenosis, and significant l- 
, 2., and 3. vessel CAD were 222 f 85, 248 f 80. 242 f 74, 250 + 96, and 262 * 114, 
respectively (p=O.O2). Mean (+ SD) Lp-PLAZ levels in pts with acute myocardial infarc- 
flon (n=33), unstable angina (n=l25), or no acute coronary syndromes (n=346) were 252 
* 77, 244 + 83, and 244 f 96, respectively (p=O.t38). Lp-PLAP levels correlated with gen- 
der, current smoking, hypertension, total cholesterol, triglycerides. LDL and HDL choles- 
terol, but not with age. However, affer adjusting for these clinical and lipid variables, Lp- 
PLAP was no longer independently predictive of anglographic CAD (p=O.63). 
Conclusion: Lp-PLA2 levels were higher in patients with angiographic CAD. However, 
the predictive value was not Independent of traditional CAD risk factors in this study. The 
association between Lp-PlA2 and outcomes I” this population is currently under Invesfi- 
gafion. 
9:30 a.m. 
840-5 Plasma C-Reactive Protein Is Not Elevated in Physically 
Active Postmenopausal Women Taking Hormone 
Replacement Therapy 
Brian L. Staffer. Derek T. Smith, Greta L. Hoetzer, Jared J. Greiner, Christopher A. 
DeSouza, University of Colorado Health Sciences Center, Denver, CO, University of 
Colorado at Boulder, Boulder, CO 
Background: C-reactive protein (CRP) is a strong independent predlcfor of future car- 
diovascular events. Hormone replacement therapy (HRT) increases plasma CRP con- 
centrations in postmenopausal women. In contrast, habitual physical activity lowers 
plasma CRP levels. Currently there are no data regarding the influence of regular physl- 
cat acflvity on the adverse effect of HRT use on CRP. We hypothesized that HRT-related 
increases in CAP would either be blunted or absent in postmenopausal women who reg- 
ularly perform endurance exercise. 
Methods: Using a cross-sectional study design, plasma CRP and inferleukln-6 levels 
were measured in sedentary and physically actwe (PA) postmenopausal women who 
were either taking or not faking HRT. 
Results: Plasma CRP levels were -75% higher in the sedentary users versus nonusers 
of HRT (1.9+0.3 vs. l.liO.2 mg/L; p &If; 0.01). However, there was no significant differ- 
ence in CRP levels between the PA users and nonusers of HRT (0.6*0.1 vs. 0.4&l mgl 
L). Plasma CRP concentrations were -65% lower in PA users and nonusers of HRT than 
their respective sedentary counterparts. There was no signlflcant influence of HRT us? 
on plasma inferleukin-6 concenfraf~ons I” either the sedentary or PA active women. Only 
the PA women not faking HRT demonstrated slgnificanfly lower inferleukln-6 levels com- 
pared with fhelr sedenfwy controls (1 O*O.Z vs. 1.6*0.2 pg/mL). 
Conclusions: Physically active post-menopausal women exhibited lower plasma CRP 
levels than sedentary controls. Importantly, the HRT-related elevation in plasma CRP 
concentrations observed in sedentary women was absent in physzcally active women. 
These data suggest that habitual physical activity may prevent the adverse effect of HRT 
use on CRP concentrations, pofenflally reducing the associated cardiovascular risk in 
postmenopausal women. 
9:45 a.m. 
840-6 Association Between Soluble CD40L and Asymptomatic 
Carotid Plaque 
Salvafore Now, Sfefania BasilI, Rosalba Tanfillo, Angela Falco, Valenfina Davi’, 
Giuseppina Now Batbagallo Carlo, Giovanni Davi’. University “G. D’Annunz~o’, Chiefi, 
Italy, University of Palermo, Palermo, Italy 
Background Inflammation IS a key feature of the development of afheroscleroflc plaque. 
CD40 ligand (CD40L). mediates several processes in afherogenesis and If can be 
released from the platelets upon their activation. Plasma levels of CD40L may predict 
paflenfs with features suggestwe of high-risk plaque (Eur Heart J 2002,4:292). 
Methods We tested the hypothesis that plasma levels of CD4OL in asymptomatic 
carotid plaque may predict nsk of cardiovascular (CVD) events prospecfwely. We 
enrolled 42 outpatients (26 men, 16 women; mean age, 64ilO years) with asympfomafic 
carotid sfenoses greater than 15% in either Infernal or common carotid artery by carotid 
ulfrasonography. As control group, we selected 21 subjects wlfhouf any carotid stenosis 
matched for age, sex and smoking habit. All sub]ecfs had at least a major cardiovascular 
risk factor (CRF). Plasma levels of CRP, IL-6, TGF-betal, and sCD40L were measured 
by ELISA. Subjects undergo follow-up examinations every 12 months, or when they 
experienced a clinical CVD event. Planned duraflon of follow-up was in median 8 years. 
Myocardial Infarction, angina, stroke, transient ischemic attack, carotid endarterecfomy, 
and intermittent claudicafion were considered as CVD events at follow up. 
Results Patients with asympfomafkz low-grade carotid sfenosls had significantly higher 
levels of CRP (pcO.0001). IL6 (p<O.OOOi), TGF-beta1 (p<O.OOOl) and sCD46L 
(pcO.0001) than controls. Soluble CD40 Llgand showed a significant wrrelafion with 
CRP (Rhw0.59, P<O.OOOl). A subgroup analysis of soluble CD40 ligand dlsfribufion 
showed that ifs plasma levels were still higher in patients compared to controls irrespec- 
tively of any CRF. No patient was lost to follow-up. Durmg follow-up, 14 (33%) patients 
experienced a CVD event. Forward sfepwise Cox regression was used to search for the 
relevance of inflammatory vanables for the prediction of these events. Only high CD40L 
levels [Hazard Ratio: 5.96; 95% confidence interval, 1 .I33 to 19.42, p=OO3] independently 
predict the risk of CVD events. 
Conclusions: High levels of CD40L may predict risk of CVD events prospectively m 
patients wfh asymptomatic carotid plaque. 
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1152-i 20 Downregulation of Insulin-Like Growth Factor-i 
Receptor in Atherosclerotic Plaque: Role of Oxidized 
Low-bensity Lipoprotein and PPARy 
Tao Peng Jie Du, Koichi One. Hiroyuki Ifabe, Yusuke Higash!, Arkady Goubine, Patrice 
Delafonfame, The Universlfy of Kansas Medical Center, Kansas City, KS 
OxLDL has multiple proafherogenic effects including promof~on of apopfosis. We have 
recently shown that OxLDL markedly downregulates insulin-like growth factor-l (IGF-1) 
and IGF-1 Receptor (IGF-iR) in vascular smooth muscle cells (VSMC) providing a 
potential mechanism for OxLDL pro-apopfofic effects. To determine mechanisms of 
OxLDL regulation of IGF-1 R we exposed human VSMC to O-100 ug/ml OxLDL or native 
LDL (nLDL) and measured IGF-1R expression by western blotting. While 100 @ml 
nLDL upregulated IGF-1R expression (39%. n=5, p<.O5), OxLDL dose dependently 
downregulated IGF-1 R (61% reduction with 100 uglml, n=5, p-=0.05) and induced VSMC 
apopfosis as defected by DNA fragmenfafwn and increased caspase-3 activity. OxLDL 
frlggers multiple signaling pathways including ~38 MAPK and PPARy pathways. To eluci- 
date mechanisms of OxLDL downregulation of IGF-1R we inhibited ~38 MAPK using 10 
uM 582035130 and blunted OxLDL downregulation of IGF-1 R by 53% (n=3, ~~0.05). This 
was confirmed by infection of VSMC wfh adenoviruses overexpress~ng dominant nega- 
five ~38 MAPK or ifs upstream klnase MKK3. PPARy IS expressed in afheroscleroflc 
plaque. To assess ifs potential mvolvemenf in OxLDL effects on IGF-1R we exposed 
VSMC lo O-100 us/ml OxLDL with or without the PPARy inhibitor PGFP ct, 200 nM. 
Although PGF2 a did not block OxLDL downregulation of the IGF-1R. surprisingly 
PPARy inhlbifion upregulated basal IGF-1R levels (340% increase, n=5). Furthermore, 
the synthetic PPAW I,gand, ciglltazone IO uM, downregulated IGF-IR levels (50% 
decrease, n=4, p<O.O5). Inhibition of scavenger receptor A and B using 40 nM fucoidin or 
anti-CD36 antibody respectively. did not block OxLDL downregulation of IGF-1 R. In con- 
clusion: 
1. OxLDL downregulates IGF-1 R wa a ~38 MAPK dependent, PPARy independent pafh- 
way not involving the classical scavenger receptors A and B. 
2. PPARy activation downregulates IGF-IR in VSMC. providing a new target for PPARy 
effects on the vasculafure. These findings provide Important waghfs info mechanisms 
whereby OxLDL triggers apopfosis of VSMC and provide a new paradigm for the 
pofenflal role of PPARyln atherosclerosis. 
